朗诗绿色地产(00106.HK)首三月签约销售按年增2.08倍至109亿人币
朗诗绿色地产(00106.HK)公布未经审核营运数据,今年1月至3月期间实现签约销售额按年增加2.08倍至109亿元人民币(下同),去年底开发服务锁定合同额约11.5亿元,其中3亿元於今年首三个月内获确认。
公司并指,去年美国地产业务受疫情影响严重,工程建设及房屋交付延期,截至去年底,美国地产业务已售未结订单货值按年增长3.46倍至27.2亿元。出於谨慎性原则,公司於去年内对位於纽约地区的Avora等项目进行了减值计提。随着美国疫情的逐步控制及纽约楼市的复苏,Avora项目去化速度提升,迄今已有90%售出。平均销售单价相比去年同期亦有所上升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.